Abbott Laboratories news from FierceHealthcare
NewsMidei: Abbott sales reps slipped into hospital's cath lab
Sworn testimony from Dr. Mark Midei in the lawsuit that alleges he implanted unnecessary stents, raises new questions about whether salespeople are getting too "chummy" with physicians and Read more...
Stent maker paid notorious cardiologist to use device
Looks like the case against Dr. Mark Midei--the Maryland surgeon accused of implanting hundreds of unnecessary cardiac stents in patients since at least 2007--has become a lot more interesting, with Read more...
CDC wants HIV tests to be included in routine medical care
National HIV testing day is June 27, and in the run up to it, the Centers for Disease Control and Prevention is pushing its recommendations that everyone get tested for HIV at least once between the Read more...
Group says YouTube medical device ads may be illegal
A consumer group has raised a protest over a group of ads for medical devices running on video site YouTube, arguing that the ads may be illegal. The group, Prescription Project, would like to see Read more...
ALSO NOTED: States sue Abbott, claiming it blocked generics; SEC helps troubled hospital bond holders; and much more...
> Eighteen states are suing Abbott Laboratories, saying it blocked generic competition for its popular cholesterol medication TriCor. Read more...
Trend: Heart stent maker markets directly to patients
Here's something you don't see every day. A heart stent manufacturer, Johnson & Johnson subsidiary Cordis Corp., is mounting a national marketing campaign aimed directly at consumers--an unusual Read more...
ALSO NOTED: Judge supports Abbott in latest stent dispute; Statins recommended for kids; and much more...
> A federal judge ruled a 2006 settlement between Abbott Laboratories and Israel's Medinol Ltd. gives Abbott wide latitude to sell drug-coated stents in the U.S. Read more...
ALSO NOTED: General Electric ends Abbott buyout plan; Tobacco interests get states to cut back on anti-smoking ads; and much mo
> General Electric Co. has ended its effort to acquire Abbott Laboratories' in-vitro and point of care diagnostics businesses, which had 2006 sales of $2.7 billion. Read more...
JPMorgan, GE make healthcare acquisitionsWall Street heavyweights JPMorgan Chase and General Electric were both involved in healthcare acquisitions reported since yesterday. JPMorgan said today that it has purchased the assets of healthcare transaction processor FisaCure for an undisclosed amount. The financial services giant will integrate FisaCure's receivables and payables technology into the Healthcare Solutions business of JPMorgan Chase's Treasury Services division. Meanwhile, several published reports indicate that … Read more...ALSO NOTED: Louisville heartcenter opens; "Ad police" hit OTC marketing; and much more...> Jewish Hospital and the University of Louisville have opened the Cardiovascular Innovation Institute in downtown Louisville, Ky., a $28 million facility to research new treatments for congestive heart failure. Report > The "advertising police" are cracking down on OTC marketing from Johnson & Johnson, Abbott Laboratories and Pfizer. … Read more... | Press ReleasesNovo Nordisk, Roche, Amgen Score Top Marks in 2011 CenterWatch Global Site SurveyBOSTON--(BUSINESS WIRE)-- A new CenterWatch survey released today shows drug sponsors have continued to improve their relationships with investigative sites by focusing on strategies to improve site Read more >> Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission MINNEAPOLIS--(BUSINESS WIRE)-- Read more >> |
